National Cancer Institute; Notice of Closed Meetings, 57946 [2014-22892]

Download as PDF 57946 Federal Register / Vol. 79, No. 187 / Friday, September 26, 2014 / Notices 48. Joan Rosof, Lafayette, Colorado, Court of Federal Claims No: 14– 0766V 49. Jennifer Ratterman, Newport, Kentucky, Court of Federal Claims No: 14–0767V 50. Patty Ferraro on behalf of A.F., Venice, Florida, Court of Federal Claims No: 14–0770V 51. Kenneth Shores, Grants Pass, Oregon, Court of Federal Claims No: 14–0771V 52. Timothy Steinruck on behalf of E.J.S., Deceased, Amherst, New Hampshire, Court of Federal Claims No: 14–0772V 53. Genice Jarman, Naples, Florida, Court of Federal Claims No: 14– 0773V 54. Wiley Terry, Sarasota, Florida, Court of Federal Claims No: 14–0774V 55. Jill Buchignani-Calwhite, Tampa, Florida, Court of Federal Claims No: 14–0775V 56. Jamie Rothstein, Philadelphia, Pennsylvania, Court of Federal Claims No: 14–0778V 57. Jaswinder Singh, Carlsbad, California, Court of Federal Claims No: 14–0779V 58. Richard J. Michel, Phillipsburg, New Jersey, Court of Federal Claims No: 14–0781V 59. Kristin Lintz, Bloomington, Indiana, Court of Federal Claims No: 14– 0784V 60. Cynthia Hamilton and Robert Hamilton on behalf of R.M.H., New York, New York, Court of Federal Claims No: 14–0785V 61. Cheryl Simmons, Wilmington, Delaware, Court of Federal Claims No: 14–0788V 62. Michelene Falsini, Salem, New Hampshire, Court of Federal Claims No: 14–0789V 63. Michael McCollum, Seaside, California, Court of Federal Claims No: 14–0790V 64. Linda Heeg, Marshfield, Wisconsin, Court of Federal Claims No: 14– 0795V 65. Jacqueline Freeman, Lexington, North Carolina, Court of Federal Claims No: 14–0796V [FR Doc. 2014–23026 Filed 9–25–14; 8:45 am] BILLING CODE 4165–15–P mstockstill on DSK4VPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. VerDate Sep<11>2014 19:14 Sep 25, 2014 Jkt 232001 The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; R13 Conference Grant Review. Date: October 30, 2014. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W556, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Bratin K. Saha, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W556, Rockville, MD 20850, 240–276–6411, sahab@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Omnibus SEP–1. Date: November 4–5, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Zhiqiang Zou, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W242, Bethesda, MD 20892–9750, 240–276–6372, zouzhiq@ mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Training and Career Development Application Review. Date: December 3, 2014. Time: 2:00 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W110, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Robert Bird, Ph.D., Chief, Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, 7W110, Bethesda, MD 20892, 240–276–6344, birdr@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: September 22, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–22892 Filed 9–25–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; NHLBI Mentored Patient-Oriented Research Review Committee. Date: October 22–23, 2014. Time: 8:30 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Stephanie Johnson Webb, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7196, Bethesda, MD 20892, 301– 435–0291, stephanie.webb@nih.gov. Name of Committee: Heart, Lung, and Blood Initial Review Group; NHLBI Mentored Clinical and Basic Science Review Committee. Date: October 23–24, 2014. Time: 10:30 a.m. to 11:00 a.m. Agenda: To review and evaluate grant applications. Place: Hilton Crystal City, Arlington, VA 22202. Contact Person: Keith A. Mintzer, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room E:\FR\FM\26SEN1.SGM 26SEN1

Agencies

[Federal Register Volume 79, Number 187 (Friday, September 26, 2014)]
[Notices]
[Page 57946]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-22892]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; R13 Conference Grant Review.
    Date: October 30, 2014.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W556, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Bratin K. Saha, Ph.D., Scientific Review 
Officer, Program Coordination and Referral Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W556, Rockville, MD 20850, 240-276-6411, 
sahab@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Omnibus SEP-1.
    Date: November 4-5, 2014.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: Zhiqiang Zou, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, 9609 Medical Center Drive, Room 7W242, Bethesda, 
MD 20892-9750, 240-276-6372, zouzhiq@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Training and Career Development Application Review.
    Date: December 3, 2014.
    Time: 2:00 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W110, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Robert Bird, Ph.D., Chief, Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, 7W110, Bethesda, MD 20892, 240-276-6344, 
birdr@mail.nih.gov.
    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 22, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-22892 Filed 9-25-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.